Qiagen
Update in progressQGEN (NYSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDiagnostics & Research
QIAGEN N.V. provides sample-to-insight solutions that transform biological samples into molecular information. It offers sample technology consumables for stabilization, purification, and automated processing for genotyping, gene expression, and viral and bacterial analysis, plus silica membranes, magnetic beads, secondary consumables, and purification instruments. It supplies immune, oncology, reproductive health, prenatal, STI, and genomic variant assays, NGS panels and library prep, DNA methylation analysis, bioinformatics, and SaaS. Founded 1984, based in Venlo, Netherlands.
Company score
- Sentiment
- 0.23
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.42
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -0.03
- Governance
- 0.00
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.13
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.18
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!